Product Information
SINUS CONGST-PAIN 325-200-5 MG is a generic product labeled by Cardinal Health, priced at $0.1111 per EA under NDC 70000008001. Its NADAC has been published 268 times since Aug 18, 2021.
SINUS CONGST-PAIN 325-200-5 MG
ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDEStrength
325; 200; 5 mg/1; mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000008001
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M012On Market Since
1/27/2021
Pharmacological Classes
Price Statistics
The NADAC for SINUS CONGST-PAIN 325-200-5 MG has been published 268 times since Aug 18, 2021, and over the history we have for it it has risen 5.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1111 per EA |
|---|---|
| All-time high | $0.1247 (Aug 10, 2022) |
| All-time low | $0.1016 (Apr 20, 2022) |
| 52-week high | $0.1167 |
| 52-week low | $0.1047 |
| Median price | $0.1083 |
| Average price | $0.1098 |
| Largest weekly change | +17.7% (Jul 20, 2022) |
| Weeks tracked | 268 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ACETAMINOPHEN, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SINUS CONGST-PAIN 325-200-5 MG?
The current National Average Drug Acquisition Cost (NADAC) for SINUS CONGST-PAIN 325-200-5 MG, manufactured by Cardinal Health, is $0.1111 per EA (NDC 70000008001), effective Sep 30, 2026.
How has the price of SINUS CONGST-PAIN 325-200-5 MG changed over time?
Over the history we have for it, the NADAC for SINUS CONGST-PAIN 325-200-5 MG has risen 5.0%. It has been tracked across 268 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for SINUS CONGST-PAIN 325-200-5 MG?
Since Aug 18, 2021, the NADAC for SINUS CONGST-PAIN 325-200-5 MG has ranged from a low of $0.1016 (Apr 20, 2022) to a high of $0.1247 (Aug 10, 2022), with a median of $0.1083 per EA.
Are there cheaper alternatives to SINUS CONGST-PAIN 325-200-5 MG?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as SINUS CONGST-PAIN 325-200-5 MG in a comparable dosage form, but none are currently priced below it.
Who manufactures SINUS CONGST-PAIN 325-200-5 MG?
SINUS CONGST-PAIN 325-200-5 MG (NDC 70000008001) is labeled by Cardinal Health, and CMS classifies it as a generic product.